Regulation of macrophage function in tumors: the multifaceted role of NF-κB

被引:187
|
作者
Hagemann, Thorsten [2 ]
Biswas, Subhra K. [3 ]
Lawrence, Toby [2 ]
Sica, Antonio [4 ,5 ]
Lewis, Claire E. [1 ]
机构
[1] Univ Sheffield, Sch Med, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England
[2] Barts & London Queen Marys Sch Med & Dent, Ctr Canc & Inflammat, Inst Canc, London, England
[3] Agcy Sci Technol & Res, Lab Human Innate Immun, Singapore Immunol Network, Inst Biomed Sci, Singapore, Singapore
[4] IRCCS, Ist Clin Humanitas, Milan, Italy
[5] Univ Piemonte Orientale, DiSCAFF, Novara, Italy
基金
英国医学研究理事会;
关键词
TOLL-LIKE RECEPTORS; INDUCED GENE-EXPRESSION; NITRIC-OXIDE SYNTHASE; SUPPRESSOR-CELLS; MYELOID CELLS; IKK-BETA; ALTERNATIVE ACTIVATION; CYCLOOXYGENASE-2; GENE; TRANSCRIPTION FACTORS; IMMUNE DYSFUNCTION;
D O I
10.1182/blood-2008-12-172825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pivotal role of tumor-associated macrophages (TAMs) in tumor progression is now well established. TAMs have been shown to influence multiple steps in tumor development including the growth, survival, invasion, and metastasis of tumor cells as well as angiogenesis and lymphangiogenesis in tumors. The molecular circuits that polarize TAMs toward such a protumoral phenotype are now the focus of intense investigation. The transcription factor, nuclear factor-kappa B (NF-kappa B), is a master regulator of many cellular processes and been shown to regulate various pathways that impact on the function of TAMs. Much evidence for this has come from the use of elegant transgenic murine tumor models in which modification of single components of the NF-kappa B signaling pathway has been shown to regulate the pro-tumor repertoire of TAMs. Here, we outline this evidence and attempt to reconcile the various views that have emerged recently over the exact role of NF-kappa B in this phenomenon. (Blood. 2009; 113:3139-3146)
引用
收藏
页码:3139 / 3146
页数:8
相关论文
共 50 条
  • [31] Differential regulation of NF-κB activation and function by topoisomerase II inhibitors
    Kirsteen J Campbell
    John M O'Shea
    Neil D Perkins
    BMC Cancer, 6
  • [32] Differential regulation of NF-κB activation and function by topoisomerase II inhibitors
    Campbell, Kirsteen J.
    O'Shea, John M.
    Perkins, Neil D.
    BMC CANCER, 2006, 6 (1)
  • [33] NF-κB:: A multifaceted transcription factor regulated at several levels
    Schmitz, ML
    Mattioli, I
    Buss, H
    Kracht, M
    CHEMBIOCHEM, 2004, 5 (10) : 1348 - 1358
  • [34] The role of Nf-κB in atherosclerosis
    Hofker, MH
    Kanters, E
    Gijbels, MJJ
    Van der Made, I
    Vergouwe, M
    Pasparakis, M
    Heeringa, P
    Kraal, G
    de Winther, MPJ
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 60 - 60
  • [35] The Role of NF-κB in Neuroinflammation
    I. I. Babkina
    S. P. Sergeeva
    L. R. Gorbacheva
    Neurochemical Journal, 2021, 15 : 114 - 128
  • [36] The Role of NF-κB in Neuroinflammation
    Babkina, I. I.
    Sergeeva, S. P.
    Gorbacheva, L. R.
    NEUROCHEMICAL JOURNAL, 2021, 15 (02) : 114 - 128
  • [37] An unexpected role for NF-κB
    Marta Tufet
    Nature Reviews Immunology, 2007, 7 : 751 - 751
  • [38] Role of NF-κB in the skeleton
    Novack, Deborah Veis
    CELL RESEARCH, 2011, 21 (01) : 169 - 182
  • [39] Role of NF-κB in the skeleton
    Deborah Veis Novack
    Cell Research, 2011, 21 : 169 - 182
  • [40] Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
    Zordoky, Beshay N. M.
    El-Kadi, Ayman O. S.
    CURRENT DRUG METABOLISM, 2009, 10 (02) : 164 - 178